Roche

Switzerland: a life sciences hub

A strong pharma and biotech history and presence. Among the top five big pharma companies, Novartis and Roche both originated and are headquartered in Switzerland. ... The FDA has just granted Roche emergency use authorisation (EUA) for its new test to

Keytruda doubles five-year survival rate in NSCLC

That includes Roche’s PD-L1 inhibitor Tecentriq (atezolizumab) which is approved for first-line SCLC.

AZ’s Tagrisso cuts risk of EGFR-positive NSCLC spreading to the brain

including AZ’s own Iressa (gefitinib) and Roche’s Tarceva (erlotinib).

Lilly’s Olumiant combined with Gilead’s remdesivir hits the mark in COVID-19

This includes Sanofi’s Kevzara (sarilumab) and Roche’s Actemra (tocilizumab), although both of these drugs failed their respective studies in COVID-19. ... Despite the disappointing results, Roche is continuing its investigation of Actemra in severe

Roche’s Ocrevus boasts positive long-term data in MS

Swiss pharma company Roche has released new long-term data that shows 75% of relapsing-remitting multiple sclerosis (RRMS) patients treated with Ocrevus (ocrelizumab) had no evidence of disease activity after ... Levi Garraway, chief medical officer and

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]